Patterns of psychotropic medication use by race among veterans with bipolar disorder

Psychiatric Services

Volumn 57, Issue 1, 2006, Pages 123-126

  Kilbourne, Amy M ^a,b   Pincus, Harold Alan ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LOXAPINE; MESORIDAZINE; MOLINDONE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CAUCASIAN; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; FEMALE; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; RACE DIFFERENCE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; UNITED STATES; VETERAN;

BIPOLAR DISORDER; DRUG UTILIZATION; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS;

EID: 30144436109     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.57.1.123     Document Type: Article

References (11)

1. Bauer MS, Kirk G, Gavin C, et al: Correlates of functional and economic outcome in bipolar disorder: a prospective study. Journal of Affective Disorders 65:231-241, 2001
2. Department of Health, Education, and Welfare Medical Practice Project: A State-of-the-Science Report for the Office of the Assistant Secretary for the U.S. Department of Health, Education, and Welfare. Baltimore, Md, Policy Research, 1979
3. Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Rockville, Md, Center for Mental Health Services, 2001. Available at www.mentalhealth.org/ cre/toc.asp
4. Melfi CA, Croghan TW, Hanna MP, et al: Racial variation in antidepressant treatment in a Medicaid population. Journal of Clinical Psychiatry 61:16-21, 2000
5. Daumit GL, Crum RM, Guallar E, et al: Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Archives of General Psychiatry 60:121-128, 2003
6. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992
7. Sajatovic M, Blow FC, Ignacio RV, et al: Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatric Services 55:1014-1021, 2004
8. Kilbourne AM, Haas GL, Mulsant B, et al: Concurrent psychiatric diagnoses by age and race among persons with bipolar disorder. Psychiatric Services 55:931-933, 2004
9. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Journal of Clinical Psychiatry 65:267-272, 2004
10. Gunnell D, Saperia J, Ashby D: Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRAs safety review. British Medical Journal 19:330, 385, 2005
11. Strickland TL, Lin KM, Fu P, Anderson D, et al: Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biological Psychiatry 37:325-30, 1995